133 related articles for article (PubMed ID: 37338457)
21. miR-147a targets ZEB2 to regulate ox-LDL-induced monocyte adherence to HUVECs, atherosclerotic plaque formation, and stability in atherosclerosis.
Chen F; Ning Y; Liu J; Lian M; Wang J; Dan H
J Biol Chem; 2023 Jun; 299(6):104657. PubMed ID: 37001814
[TBL] [Abstract][Full Text] [Related]
22. Engineering ROS-scavenging Prussian blue nanozymes for efficient atherosclerosis nanotherapy.
Chen X; Dai C; Hu R; Yu L; Chen Y; Zhang B
J Mater Chem B; 2023 Mar; 11(9):1881-1890. PubMed ID: 36723250
[TBL] [Abstract][Full Text] [Related]
23. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
24. Neopterin derivatives - a novel therapeutic target rather than biomarker for atherosclerosis and related diseases.
Watanabe T
Vasa; 2021 Apr; 50(3):165-173. PubMed ID: 32924886
[No Abstract] [Full Text] [Related]
25. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
26. Andrographolide Ameliorates Atherosclerosis by Suppressing Pro-Inflammation and ROS Generation-Mediated Foam Cell Formation.
Wu T; Peng Y; Yan S; Li N; Chen Y; Lan T
Inflammation; 2018 Oct; 41(5):1681-1689. PubMed ID: 29948505
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin.
Cheraga N; Ye Z; Xu MJ; Zou L; Sun NC; Hang Y; Shan CJ; Yang ZZ; Chen LJ; Huang NP
Nanoscale; 2022 Jun; 14(24):8709-8726. PubMed ID: 35673987
[TBL] [Abstract][Full Text] [Related]
28. Novel phytopeptide osmotin mimics preventive effects of adiponectin on vascular inflammation and atherosclerosis.
Takahashi Y; Watanabe R; Sato Y; Ozawa N; Kojima M; Watanabe-Kominato K; Shirai R; Sato K; Hirano T; Watanabe T
Metabolism; 2018 Jun; 83():128-138. PubMed ID: 29410350
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid-guided assembly of ceria nanozymes as plaque-targeting ROS scavengers for anti-atherosclerotic therapy.
Wang S; Zhang J; Li W; Chen D; Tu J; Sun C; Du Y
Carbohydr Polym; 2022 Nov; 296():119940. PubMed ID: 36087989
[TBL] [Abstract][Full Text] [Related]
30. 5-HT
Ma Y; Liang X; Li C; Li R; Tong X; Zhang R; Shan X; Yang J; Ma X; Lu W; Li R; Fu J
J Atheroscler Thromb; 2022 Mar; 29(3):322-336. PubMed ID: 33536397
[TBL] [Abstract][Full Text] [Related]
31. Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques.
Wu H; Cheng XW; Hu L; Hao CN; Hayashi M; Takeshita K; Hamrah MS; Shi GP; Kuzuya M; Murohara T
Atherosclerosis; 2014 Dec; 237(2):739-47. PubMed ID: 25463114
[TBL] [Abstract][Full Text] [Related]
32. Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.
Lu Y; Zhang M; Zhao P; Jia M; Liu B; Jia Q; Guo J; Dou L; Li J
Mol Med Rep; 2017 Jul; 16(1):647-653. PubMed ID: 28560429
[TBL] [Abstract][Full Text] [Related]
33. Using Cu-Based Metal-Organic Framework as a Comprehensive and Powerful Antioxidant Nanozyme for Efficient Osteoarthritis Treatment.
Yu B; Sun W; Lin J; Fan C; Wang C; Zhang Z; Wang Y; Tang Y; Lin Y; Zhou D
Adv Sci (Weinh); 2024 Apr; 11(13):e2307798. PubMed ID: 38279574
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
[TBL] [Abstract][Full Text] [Related]
35. Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy.
Liu Y; Cheng Y; Zhang H; Zhou M; Yu Y; Lin S; Jiang B; Zhao X; Miao L; Wei CW; Liu Q; Lin YW; Du Y; Butch CJ; Wei H
Sci Adv; 2020 Jul; 6(29):eabb2695. PubMed ID: 32832640
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of vasostatin-1 against atherogenesis.
Sato Y; Watanabe R; Uchiyama N; Ozawa N; Takahashi Y; Shirai R; Sato K; Mori Y; Matsuyama T; Ishibashi-Ueda H; Hirano T; Watanabe T
Clin Sci (Lond); 2018 Dec; 132(23):2493-2507. PubMed ID: 30401690
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
[TBL] [Abstract][Full Text] [Related]
39. Self-cascade MoS
Zhang X; Zhang S; Yang Z; Wang Z; Tian X; Zhou R
Nanoscale; 2021 Aug; 13(29):12613-12622. PubMed ID: 34264260
[TBL] [Abstract][Full Text] [Related]
40. PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice.
Wu Y; Xie G; Xu Y; Ma L; Tong C; Fan D; Du F; Yu H
J Transl Med; 2015 Sep; 13():316. PubMed ID: 26410585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
